Navigation Links
ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi
Date:6/9/2011

IRVINE, Calif. and OXFORD, Miss., June 9, 2011 /PRNewswire/ -- ChromaDex Corp. (OTCBB: CDXC) and the University of Mississippi today announced the university has granted the natural products company the exclusive worldwide patent rights to a potential new therapeutic use for pterostilbene (tero-STILL-bean) as an anxiolytic or anti-anxiety agent. ChromaDex' pTeroPure® is an ultra-pure formulation of pterostilbene, a compound found in blueberries and demonstrated to have multiple health benefits.

ChromaDex continues its strategy of expanding its intellectual property supporting pterostilbene as the company builds its pTeroPure product portfolio and seeks partnerships to enter new markets. ChromaDex previously licensed two patents from the University of Mississippi that focus on the ability of pterostilbene to reduce blood lipoprotein levels and pterostilbene's effect on oxidative stress and cognition. ChromaDex also holds rights to patents related to manufacturing claims.

"Adding the anxiolytic indication to our existing patent portfolio around pTeroPure allows us to capitalize on new product opportunities that we can pursue independently or with partners looking to differentiate their own products," said ChromaDex President William Spengler. "ChromaDex will continue to seek partners such as the University of Mississippi so as to capture advancements in natural product research that will allow us to provide the marketplace with innovative proprietary ingredients."

Research conducted by the University of Mississippi School of Pharmacy shows pterostilbene may have anxiolytic activities. The researchers determined pterostilbene activates the ERK signaling pathway in the hippocampus, an area of the brain speculated to play a role in anxiety. The effect of pterostilbene was investigated in a classic animal model of anxiety and found to be comparable in activity to the anti-anxiety drug diazepam used as the control drug in the mod
'/>"/>

SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Life Extension® Launches New Product Containing ChromaDexs pTeroPure® Pterostilbene
2. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
3. ChromaDex and Bruker Optics Sign Agreement to Expedite Dietary Supplement Testing for Compliance With FDA Good Manufacturing Practice Requirements
4. ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
5. Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
6. Biomerix Awarded Two Device Licenses by Health Canada
7. China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products
8. Oxford BioTherapeutics Licenses BioWas POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
9. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
10. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
11. Novavax Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences for South Korea and Other Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 Today, the Pharmaceutical Research ... from 12 biopharmaceutical companies as "We Work For ... advocacy and community service. Established in ... were created by the biopharmaceutical industry to honor ... careers, but have also shown an outstanding commitment ...
(Date:4/17/2015)... Va. , April 17, 2015   ... distribution of radiopharmaceuticals, announced today that it has signed ... Molecular North America, Inc. (IBAM NA), to Illinois Health and ... to operate as an independent company headquartered in ... positioned to take advantage of new product and footprint ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) ... of Pharma in 2014 - a Perspective of Mental ... their offering. For the first time, in ... reputation of the pharmaceutical industry held by patient groups ... of patient organisations representing all therapy areas. ...
Breaking Medicine Technology:PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... and TORONTO, Sept. 7, 2011 Generex Biotechnology ... that Mark Fletcher, the Company,s President & Chief ... of the Company,s wholly-owned subsidiary, Antigen Express, Inc. ... at  the Rodman & Renshaw 13th Annual Healthcare ...
... YORK, Sept. 7, 2011 ACCESS PHARMACEUTICALS, ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms to ... and diabetes, announced that it has contracted with CuraScript, ... expand its specialty pharmacy and third party logistics networks ...
Cached Medicine Technology:Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 2Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 4
(Date:4/17/2015)... April 17, 2015 “We have seen healing, ... the past and present,” said Chaplain Shawn Kafader of Friendship ... felt like they had anything to contribute have created beautiful ... overseen a new art therapy program that was launched to ... Masters student from School of the Art Institute in Chicago, ...
(Date:4/17/2015)... In Defense of Christians (IDC) Executive Director ... April 15th, the European Parliament joined its voice with ... Armenian Genocide, “paying tribute, on the eve of the ... Armenian victims who perished in the Ottoman Empire.” ... this timely and needed recognition of a tragic episode ...
(Date:4/17/2015)... DC (PRWEB) April 17, 2015 Representatives ... HHT Diagnoses and Treatment Act HR 1849 in congress ... diagnosis rates and treatment for patients with the genetic ... in the past, would be the first to create ... and appropriate treatment of hereditary hemorrhagic telangiectasia. This would ...
(Date:4/17/2015)... Hills, California (PRWEB) April 17, 2015 ... stands above in his new offering of platelet-rich plasma ... Orthopedic Sports Medicine (MOSM) is known for its ... Dr. Meier brings extensive surgical experience lacking in many ... and stem cell treatments are utilized for pain management ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Most dental ... dental restoration units are made overseas by foreign dental ... domestic labs remain unregulated in more than 40 states ... National Association of Dental Laboratories has created ... raise awareness among patients about the consequences that could ...
Breaking Medicine News(10 mins):Health News:Healing At Friendship Village Due To Art Therapy 2Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:National Association Urges Transparency in Dental Industry 2
... TORONTO, Nov. 12 /PRNewswire-FirstCall/ - Transition Therapeutics Inc.,("Transition" or ... hold a,conference call on Wednesday, November 14, 2007 at ... financial results. Dr. Tony Cruz, Chairman,and Chief Executive Officer ... its financial results for this period in a press ...
... Incorporated,(Nasdaq: VPHM ) today announced that the ... Medicines Agency (EMEA) has granted orphan,drug designation for ... patients with impaired cell-mediated immunity. The EMEA,s,"Orphan Medicinal ... drugs which may provide significant benefit to patients,suffering ...
... spirometry to clinical exams benefits those with symptoms , MONDAY, ... diagnosing and treating the lung illness known as stable ... American College of Physicians (ACP). , COPD, typically caused ... affects more than 5 percent of American adults and is ...
... Now has,selected its $7,500 Grand Prize winner in its ... walks away with the big prize,after a 3-month competition ... will receive $250 in the contest. The winning video ... "Brendan Hayward captured, in just 30 seconds, what ...
... Mich., Nov. 12 Leading health care risk,management ... third,quarter results for the period ended Sept. 30, ... quarter and first nine months of the year. ... medical,professional liability insurance and integrated risk management products,and ...
... Medical,Association (AMA) proudly presented Portland physician Richard Allen, ... its semi-annual,policy-making meeting. Dr. Allen is the first ... for meritorious service in the science and art,of ... advancing medical education," said,AMA President Ron Davis, M.D. ...
Cached Medicine News:Health News:Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2008 Financial Results on Wednesday, November 14, at 8:30 A.M. EST 2Health News:ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM) 2Health News:ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM) 3Health News:ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM) 4Health News:New Guideline Targets Treatment of Stable COPD 2Health News:Psoriasis Cure Now Video Contest $7,500 Grand Prize Winner Announced 2Health News:FinCor Holdings Posts Double-Digit Increases in Revenue and Net Income for Third Quarter 2Health News:FinCor Holdings Posts Double-Digit Increases in Revenue and Net Income for Third Quarter 3Health News:Portland Physician Wins AMA Distinguished Service Award 2
... The PipetBoy Pipettor is light as a feather ... aspiration speed can be continuously adjusted. The pipette ... be autoclaved. Two dosing knobs enable fine dosing ... plastic an/or glass pipettes from 0.1 to 100 ...
Precise, safe, and fatigue-free series pipetting using graduated pip...
Inquire...
Inquire...
Medicine Products: